EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular Subtypes

Megan L Ludwig iD, Ali T Arafa, Saasha Vinoo, Jason C Jones iD, Abderrahman Day, Hannah E Bergom, Zoi Sychev, Alec Horrmann, Nicholas M Levinson, Scott M Dehm, Emmanuel S Antonarakis, Justin Hwang und 1 weitere

Journal of Extracellular Vesicles · 2025

DOI: 10.1002/jev2.70176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2025. Verfasst von Megan L Ludwig und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Prostatic Neoplasms, Proteomics. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Masonic Cancer Center, University of Minnesota, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer is the most common non‐cutaneous cancer among men in the United States. Most prostate cancers are driven by androgen receptor (AR) signalling, but there are an increasing number of cases that lose AR and gain neuroendocrine (NE) features (AR−/NE+) or lack both (AR−/NE−). These latter subtypes are particularly aggressive and lethal. Extracellular vesicles (EVs) have shown great potential as biomarkers for non‐invasive liquid biopsy assays, as EVs contain biomolecules from their cells of origin. Here, we used a shotgun proteomics approach with mass spectrometry to interrogate the global proteome of EVs isolated from prostate cancer cell lines reflecting diverse clinical subtypes, including AR−/NE+ and AR−/NE− models. We identified 3952 EV proteins, which clustered largely by tumour subtype and provided enough proteomic coverage to derive classic gene signatures of AR or NE identity that are of high relevance for prostate cancer prognostication. EVs isolated from AR+ cells displayed high levels of proteins regulated by AR and mTOR signalling. EVs isolated from AR−/NE+ cells contained known NE markers such as SYP and CHGA, whereas EVs from AR−/NE− models were enriched in basal cell markers and proteins that regulate epithelial‐to‐mesenchymal transition (EMT). We integrated our cell line data with recently published EV proteomics data from 27 advanced prostate cancer patients and found 2733 overlapping proteins, including cell surface markers relevant to prostate cancer, AR activity indicators, and proteins enriched in specific subtypes (AR+, AR−/NE−, AR−/NE+). This approach may be useful for rare cancer subtypes, such as prostate cancers that lose AR‐related features and gain NE features, to optimise the use of these liquid biopsy samples for clinical decision making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesProstatic NeoplasmsProteomicsHumansMaleReceptors, AndrogenCell Line, TumorBiomarkers, TumorProteome

Substanzen

Receptors, AndrogenBiomarkers, TumorAR protein, humanProteome

Autor:innen und Institutionen

  • Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Urology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Megan L Ludwig, Jason C Jones

Förderung

  • NCI NIH HHS
  • Masonic Cancer Center, University of Minnesota
  • NIH HHS
  • U.S. Department of Defense
  • American Cancer Society
  • National Cancer Institute

Zitieren

APA

Ludwig, M. L., Arafa, A. T., Vinoo, S., Jones, J. C., Day, A., Bergom, H. E., Sychev, Z., Horrmann, A., Levinson, N. M., Dehm, S. M., Antonarakis, E. S., Hwang, J., & Drake, J. M. (2025). Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular Subtypes. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70176

Vancouver

Ludwig ML, Arafa AT, Vinoo S, Jones JC, Day A, Bergom HE, et al. Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular Subtypes. Journal of Extracellular Vesicles. 2025. doi:10.1002/jev2.70176

BibTeX
@article{Ludwig2025,
  author = {Ludwig, Megan L and Arafa, Ali T and Vinoo, Saasha and Jones, Jason C and Day, Abderrahman and Bergom, Hannah E and Sychev, Zoi and Horrmann, Alec and Levinson, Nicholas M and Dehm, Scott M and Antonarakis, Emmanuel S and Hwang, Justin and Drake, Justin M},
  title = {Proteomic Profiling of Extracellular Vesicles Distinguishes Prostate Cancer Molecular Subtypes},
  journal = {Journal of Extracellular Vesicles},
  year = {2025},
  doi = {10.1002/jev2.70176}
}
Kostenlos starten →